SCHEMBL20031631

SCHEMBL20031631

C=C(CCCCCC/C=C\C/C=C\CCCCC)CCCCCC/C=C\C/C=C\CCCCC

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.65
PPARG P37231 5/20 0.65
F7 P08709 4/20 0.65
F3 P13726 4/20 0.65
KDM4E B2RXH2 4/20 0.65
PPARD Q03181 4/20 0.65
PPARA Q07869 4/20 0.65
FABP3 P05413 3/20 0.65
FFAR1 O14842 3/20 0.65
PTGS1 P23219 2/20 0.65
LMNA P02545 2/20 0.65
CYP3A4 P08684 2/20 0.65
CYP19A1 P11511 2/20 0.65
FABP4 P15090 2/20 0.65
HPGD P15428 2/20 0.65
ALOX15 P16050 2/20 0.65
AKR1C3 P42330 2/20 0.65
NR4A2 P43354 2/20 0.65
HSD17B10 Q99714 2/20 0.65
TDP1 Q9NUW8 2/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24986050 1.00 ALDH1A1 (0.65) ALDH1A1PPARGF7F3KDM4E
SCHEMBL24016792 0.98 ALDH1A1 (0.62) ALDH1A1PPARGF7F3KDM4E
SCHEMBL31216417 0.94 TERT (0.61) PPARGF7F3PPARDPPARA
Ammonia Solution, Strong SCHEMBL8935018 0.92 TERT (0.59) PPARGF7F3PPARDPPARA
SCHEMBL10384713 0.90 TERT (0.57) PPARGF7F3PPARDPPARA
SCHEMBL6782134 0.90 TERT (0.57) PPARGF7F3PPARDPPARA
SCHEMBL8746647 0.90 TERT (0.57) PPARGF7F3PPARDPPARA
SCHEMBL24637602 0.87 ALDH1A1 (0.51) ALDH1A1PPARGF7F3KDM4E
SCHEMBL12071438 0.86 ALDH1A1 (0.68) ALDH1A1PPARGF7F3KDM4E
SCHEMBL12179748 0.86 ALDH1A1 (0.68) ALDH1A1PPARGF7F3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11077197-B2 Lipids and compositions for the delivery of therapeutics ARBUTUS BIOPHARMA CORPORATION (CA) 2021-08-03 US disclosed
US-20180092971-A1 NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS ARBUTUS BIOPHARMA CORPORATION (CA) 2018-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11077197-B2 Lipids and compositions for the delivery of therapeutics SGMS2, APOB, MBOAT1 ALDH1A1 4491/4885PPARG 860/4885F7 1027/4885
US-20180092971-A1 NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS PHOSPHO1, SGMS2, MBOAT1 ALDH1A1 4584/4885PPARG 849/4885F7 1206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.